MedPath

A randomized controlled trial of Ninjin yoeito for lung cancer

Not Applicable
Recruiting
Conditions
lung cancer
Registration Number
JPRN-jRCTs051200009
Lead Sponsor
Tanaka Yugo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
140
Inclusion Criteria

1. Patients over 20 years old with performance status of 0-1 who were diagnosed or suspected with primary lung cancer.
2. Patients undergoing uni-lobectomy with group-2 lymphadenectomy.
3. Patients who consented to the study in writing.
4. Patients scheduled to undergo thoracoscopic surgery including robot-assisted surgery.

Exclusion Criteria

1. Patients who have history of allergies in NINJIN-YOUEI-TO in the past.
2. Patients who were treated with Kampo formulation for this symptom within 2 weeks before the start of this study.
3. Patients who have severe anorexia, nausea and vomiting which are careful administration of this drug.
4. Patients whom the doctor judged unsuitable as the subject.
5. Patients who do not retain liver function and kidney function
-Total Bilirubin <=2.0mg/dL
-Serum creatinine <=2.0mg/dL
6. Patients with conversion to open thoracotomy.
7. Patients with pulmonary resection range of 2 or more lobes.
8. Patients who cannot drink water within 3 days after surgery.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CFS (Cancer Fatigue Scale)
Secondary Outcome Measures
NameTimeMethod
Breathlessness (VAS), Cancer Dyspnea Scale, MD Anderson Symptom Inventory, Basic Check List (Flail Assessment Tool), Spirometry, Effort Force Capacity, 1 Second Amount, 1 Second Rate, Pulmonary Diffusion Ability, Weight, Blood test
© Copyright 2025. All Rights Reserved by MedPath